000 01343 a2200325 4500
005 20250517040732.0
264 0 _c20160119
008 201601s 0 0 eng d
022 _a1878-1810
024 7 _a10.1016/j.trsl.2015.06.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuirk, Shannon K
245 0 0 _aImmune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.
_h[electronic resource]
260 _bTranslational research : the journal of laboratory and clinical medicine
_cNov 2015
300 _a412-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aCTLA-4 Antigen
_ximmunology
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aIpilimumab
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aNeoplasm Metastasis
700 1 _aShure, Anna K
700 1 _aAgrawal, Devendra K
773 0 _tTranslational research : the journal of laboratory and clinical medicine
_gvol. 166
_gno. 5
_gp. 412-24
856 4 0 _uhttps://doi.org/10.1016/j.trsl.2015.06.005
_zAvailable from publisher's website
999 _c25024456
_d25024456